{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-23-000055","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.574512+00:00","generated_at":"2026-06-07T18:10:59.891870+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"GoodRx responds to CVS Health's new pharmacy reimbursement model, highlights existing acquisition-cost pricing","bullets":["GoodRx already hosts discount card pricing agreements informed by acquisition cost-based pricing at CVS Pharmacy and other key retailers.","Company plans to continue implementing acquisition cost-based approach with retail partners pursuing this model.","Sees its hybrid pharmacy contracting strategy as well positioned for evolving reimbursement models.","Disclosure follows CVS Health's recent announcement of a new pharmacy reimbursement formula based on drug cost plus markup and fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-23-000055","json":"https://secwatch.observer/filing/0001809519-23-000055.json","markdown":"https://secwatch.observer/filing/0001809519-23-000055.md","text":"https://secwatch.observer/filing/0001809519-23-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/0001809519-23-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/gdrx-20231205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:10:59.891870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}